ライフサイエンスコーパス: personal history

1 In this review, I recount my personal history.

2 ced by levels of professional experience and personal history.

3 biographical memories that define our unique personal history.

4 Most patients had no personal history (101 [98%]) or family history of psoria

5 nopausal] or ovarian cancer) (22%), positive personal history (7%), and both positive personal histor

6 ct of interventions in patients with diverse personal histories and causes of illness, often under th

7 This article relates some personal history and influences leading to becoming a pl

8 ive personal history (7%), and both positive personal history and positive family history (4%).

9 aluate them together with the patient's age, personal history, and bloodwork.

10 roach includes the key findings in patients' personal histories, clinical examination, laboratory tes

11 process ongoing experiences is shaped by our personal history, current needs, and future goals.

12 ptom checklists and provided demographic and personal history data.

13 melanoma in people at increased risk due to personal history (eg, melanoma, transplant, dysplastic n

14 years and select patients >65 years based on personal history, family history, ancestry, or eligibili

15 A brief personal history follows, including an account of a few

16 A brief personal history illustrates how fortunate I was to have

17 For women whose family or personal history is associated with an increased risk fo

18 The authors compared the personal histories, levels of psychological distress, an

19 Cases and controls had equivalent personal histories of cancers other than brain cancer an

20 her proportions of Ashkenazim with family or personal histories of CRC.

21 dy of NHL (1998-2000), the authors collected personal histories of immune-related conditions and use

22 ial hypercholesterolaemia, or with family or personal history of (very) high Lp(a) or premature ASCVD

23 Nineteen adolescent volunteers with no personal history of a psychiatric illness, but who were

24 1,041 patients provided a FIT (516 personal history of adenomas, 172 personal history of CR

25 rt study of asymptomatic high-risk patients (personal history of adenomas/CRC or family history of CR

26 had a history of first EPS after 1999 and no personal history of advanced atrioventricular block or s

27 fected if they were >60 years of age, had no personal history of AF, and had no offspring with a hist

28 ptake was particularly high in subjects with personal history of angina pectoris and familial aneurys

29 ntibiotic-resistant bacteria, independent of personal history of antibiotic consumption and other kno

30 have shown an inverse association between a personal history of atopy/allergies, both overall and am

31 h significance was lost after adjustment for personal history of BBD or family history of breast canc

32 Fifteen (36.6%) had a personal history of being given naloxone after an overdo

33 Associations of number of nevi with personal history of benign breast disease (BBD) and fami

34 , including family history of breast cancer, personal history of benign breast disease, height at age

35 t of individuals with a strong family and/or personal history of breast and ovarian cancer carry a de

36 alignancies were more common in women with a personal history of breast cancer (35% vs 10%, P = .02).

37 family history of breast cancer (FH group), personal history of breast cancer (PH group), and histor

38 often inadequate for screening women with a personal history of breast cancer (PHBC).

39 722 820 mammograms in individuals without a personal history of breast cancer and 156 104 mammograms

40 Among 424 women with personal history of breast cancer and available tumor ER

41 performed from 2007 to 2016 in women with a personal history of breast cancer and compare with data

42 itary EOC controls (defined by no associated personal history of breast cancer and no family history

43 with rates from 1996 to 2007 in women with a personal history of breast cancer and was higher than th

44 ents at elevated risk for breast cancer (eg, personal history of breast cancer or breast cancer in a

45 st MRI should be considered for women with a personal history of breast cancer or high-risk lesion.

46 equivocal for MRI screening of women with a personal history of breast cancer or high-risk lesion.

47 l of 347 women aged 25 to 69 years without a personal history of breast cancer presenting for an annu

48 nce for women aged 25 years or older with no personal history of breast cancer was analyzed, with bio

49 l indication for screening, breast symptoms, personal history of breast cancer, age, time since last

50 istory of breast cancer, 46% in women with a personal history of breast cancer, and 15% in women with

51 sed on clinical indication, breast symptoms, personal history of breast cancer, and age.

52 ng demographic risk factors (age, family and personal history of breast cancer, and use of hormone re

53 nd BRCA2 pathogenic variant carrriers with a personal history of breast cancer, as they appear to ben

54 re reviewed for age, risk factors (family or personal history of breast cancer, BRCA mutation status,

55 e age 50 years or younger, and 363 (40.2%) a personal history of breast cancer.

56 hogenic variants in BRCA1 and BRCA2 and with personal history of breast cancer.

57 second breast cancer events in women with a personal history of breast cancer.

58 gnosed in women with a genetic mutation or a personal history of breast cancer.

59 ers were in women with a genetic mutation or personal history of breast cancer.

60 patients with dense breasts and a family or personal history of breast cancer.

61 ) and patient parameters (menopausal status, personal history of breast carcinoma) by means of univar

62 .02) were 16% (15 of 92) in patients with no personal history of breast carcinoma, 13% (nine of 67) w

63 For women with personal history of breast or ovarian cancer but no fami

64 Women who have a personal history of breast or ovarian cancer significant

65 CI included increasing age, male gender, and personal history of CAD (P < 0.05 for all).

66 ed (4 of 10 [40%] vs 2 of 30 [7%]) or have a personal history of cancer (6 of 10 [60%] vs 5 of 30 [17

67 Among the 646 respondents, 414 (64%) had a personal history of cancer and 505 (78%) had at least on

68 Family or personal history of cancer did not show significant asso

69 y history of breast or ovarian cancer but no personal history of cancer or known potentially harmful

70 Adults with a personal history of cancer other than nonmelanoma skin c

71 ease control group of 135 patients without a personal history of cancer who had undergone cholecystec

72 Adjusted for age, sex, body mass index, personal history of cancer, family history of lung cance

73 ic obstructive pulmonary disease, emphysema, personal history of cancer, personal history of pneumoni

74 For patients without a personal history of cancer, the positive and negative LR

75 BRCA-related cancer and, in the absence of a personal history of cancer, would therefore be unlikely

76 sun-exposure variables, X-ray exposure, and personal history of cancer.

77 Sixteen patients (84%) had a familial or personal history of cardiac arrest.

78 in childhood vaccination decisions, mothers' personal history of cervical cancer or cervical biopsy w

79 Personal history of CHD, smoking, hypertension, low BMI,

80 uded 7,007 subjects aged >/=65 years with no personal history of CHD, stroke, or dementia, and self-r

81 demographics, health-related behaviors, and personal history of chronic diseases.

82 sk of CLL was found among individuals with a personal history of chronic rheumatic heart disease (OR

83 ents for surveillance colonoscopies due to a personal history of colon polyps.

84 of both the subject (age, gender, and family/personal history of colonic neoplasia) and the adenoma (

85 tations were unrelated to gender, family, or personal history of colonic neoplasia, location within t

86 Of 603 patients, 119 (20%) had a personal history of colorectal cancer and most (n = 461

87 Exclusion criteria included a personal history of colorectal cancer or rectal bleeding

88 for an upcoming physical examination, had no personal history of colorectal cancer, and were eligible

89 at serrated polyposis syndrome diagnosis, a personal history of colorectal cancer, size of the large

90 ple and those with increased risk based on a personal history of colorectal neoplasia.

91 ence of various cardiovascular risk factors (personal history of coronary heart disease [CHD], conges

92 frequently occurring malignancy in women, a personal history of cosmetic surgery in those undergoing

93 a FIT (516 personal history of adenomas, 172 personal history of CRC and 353 family history of CRC).

94 (+/-3 years) without S. bovis bacteremia and personal history of CRN and with increased risk of CRN (

95 No patient had a personal history of cutaneous melanoma, autoimmune disea

96 hematological malignancy, and 15 (46%) had a personal history of cytopenia years before MDS/AML diagn

97 le to that of women of similar age without a personal history of DCIS.

98 mparison group of 55 participants who had no personal history of depression and no reported depressio

99 grief reactions had higher rates of previous personal history of depression.

100 Information on personal history of diabetes and other diseases, lifesty

101 Women with a personal history of diabetes were excluded.

102 After excluding patients with personal history of diabetes, family history of DM was s

103 Both personal history of DM and family history of DM were sig

104 osis had a significantly higher incidence of personal history of duodenal ulcer (P = .02).

105 d Black patients with > 1 colonoscopy and no personal history of either inflammatory bowel disease or

106 g incrementally associated with LS carriers' personal history of endometrial (odds ratio [OR], 1.37 p

107 age, had a normal ECG and echocardiogram, no personal history of heart failure, and had no affected o

108 s with a BRCA1 or BRCA2 PV, < 50% reported a personal history of hereditary breast or ovarian-associa

109 21% for hypertension (defined by a reported personal history of hypertension or of treatment with an

110 istory of correctional control, those with a personal history of incarceration were at greater odds o

111 A structured questionnaire identified personal history of infantile colic for case and control

112 in the previous 5 years, and patients with a personal history of inflammatory bowel disease or CRC we

113 contrast material uptake in patients with a personal history of ipsilateral breast cancer.

114 A family history of OA, personal history of knee OA, or pain on climbing stairs

115 s of baseline MWS scores include female sex, personal history of melanoma, and higher Hospital Anxiet

116 In patients without a personal history of melanoma, only the new melanoma RIES

117 In patients with a personal history of melanoma, worry was reduced on all s

118 major depression were more likely to have a personal history of mood and anxiety disorders than pati

119 ased familial risk of depression but with no personal history of mood disorder.

120 e at familial risk of depression but with no personal history of mood disorder.

121 pediatricians, vegetarians, and those with a personal history of obesity were more likely to provide

122 sex, site, race, family history of melanoma, personal history of other cancer, and Surveillance, Epid

123 at CRC diagnosis, family history of CRC, nor personal history of other cancers significantly predicte

124 y sets Egypt apart from other countries is a personal history of parenteral antischistosomal therapy

125 A total of 2,653 physicians reported a personal history of periodontal disease at baseline.

126 practitioners with a private practice and a personal history of periodontal disease.

127 ignificantly increased among subjects with a personal history of pernicious anemia (OR = 1.94; 1.18-3

128 Personal history of pneumonia was associated with signif

129 ease, emphysema, personal history of cancer, personal history of pneumonia, and family history of lun

130 Family and personal history of primary open-angle glaucoma also inc

131 ts potential as a diagnostic window into the personal history of prior brain activations of both heal

132 ovarian cancer syndrome, although two had a personal history of prior cancer.

133 nder identity disorder, transsexualism, or a personal history of sex reassignment were identified, an

134 r Assessment of Risk) was trained to predict personal history of skin cancer from age, family history

135 FH of MDD, but not a personal history of STBs or MDD, was associated with rel

136 ey stones was much more common in men with a personal history of stones at baseline in 1986 than in t

137 se at higher risk of breast cancer or with a personal history of the disease.

138 Of these, 44% occurred in patients with no personal history of these conditions.

139 cases diagnosed in 12,504 subjects for whom personal history of thyroid diseases was known.

140 d any family history of breast cancer or any personal history of trauma, infection, or surgery of the

141 ed to stop their CHC, excluding those with a personal history of VTE, anticoagulation, or pregnancy.

142 tory: high (met Amsterdam criteria), medium (personal history or first-degree relative with an HNPCC-

143 raphical information that defines our unique personal history, our brains must form durable memories

144 nt (P < .001), genetic mutations (P = .006), personal history (P < .001), and first-degree family his

145 formatting and a web-server for analysis of personal history parameters, to facilitate dataset-speci

146 emission, evaluated with the Psychiatric and Personal History Schedule.

147 rform annual screening, including family and personal history taking (100%), physical examination (10

148 Regardless of family or personal history, the USPSTF found adequate evidence tha

149 Inna Golubovskaya related this personal history to the authors in conversation.

150 mbs (57% vs 42%, P < .001), and those with a personal history were more likely to have melanoma on th

151 The prevalence rates of personal history with allergic proctocolitis (23.2%) and